Monash University

Embargoed and Restricted Access

Reason: Under embargo until October 2020. After this date a copy can be supplied under Section 51(2) of the Australian Copyright Act 1968 by submitting a document delivery request through your library

The Diagnostic and Therapeutic Development of Molecular Agents for Inflammation and Thrombosis

posted on 2019-10-15, 03:13 authored by EE FANG YU
Inflammation is the body’s physiological response to minimise deleterious impact of injury or infection. However, uncontrolled inflammatory processes can be detrimental and contribute to inflammatory diseases. Inflammatory pathways also cross-talk with coagulation pathways and can increase the risk of thrombosis. As such, inflammation and thrombosis remain to be a major cause of morbidity and mortality, despite much improvement in the understanding of these diseases and drug development over the last 3 decades. My PhD project aims to develop safe and effective molecular agents that target different components of inflammatory and coagulation pathways for diagnostic and therapeutic purposes.


Principal supervisor

Karlheinz Peter

Year of Award


Department, School or Centre

Central Clinical School


Doctor of Philosophy

Degree Type



Faculty of Medicine, Nursing and Health Sciences

Usage metrics

    Faculty of Medicine, Nursing and Health Sciences Theses